We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreAccording to the UICC, “priority will be given to medicines currently on the WHO Essential Medicin...
Read moreIntroduction For some manufacturers, launching in the Middle East and North Africa (MENA) is fraught...
Read moreIntroduction As the most populous country in the world with 1.4 billion inhabitants, China has the p...
Read moreIntroduction Health Technology Assessment (HTA) implementation has been historically slow in Asia co...
Read moreIntroduction: Brazil is a market of 210 million people Brazil is the largest country in South Americ...
Read moreIn December 2021, China once again updated its National Reimbursed Drugs List (NRDL).
Read moreThe committee’s recommendations are forwarded to the Federal Ministry of Health for consideration.
Read moreThe Patented Medicine Prices Review Board (PMPRB) has a mandate to ensure that patented medicines ar...
Read moreA one stop shop for joint advice between EMA, EUnetHTA and health technology assessment bodies - the...
Read more